Brighton and Sussex Medical School and Royal Sussex County Hospital researchers have published an analysis of Francis ...

A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new AI technology.

This Comment explores the current landscape of clinical psychedelic research, highlighting the need for a systematic approach to evidence synthesis.

AI is rapidly advancing, with significant strides being made toward achieving more powerful and capable systems.

Bitopertin is an investigational agent and is not approved for use as a therapy in any jurisdiction worldwide. Disc obtained global rights to bitopertin under a license agreement from Roche in May ...

TScan Therapeutics Inc. (NASDAQ:TCRX), a clinical-stage biopharmaceutical company with a market capitalization of $139.57 million, is poised at a critical juncture in its development of innovative ...

Targeted drugs ... extensive clinical trials are needed to demonstrate that imaging of this particular process provides clinically useful information. Nunn 31 estimated that the development ...

Civica, Inc., the nonprofit drug manufacturer contracted to produce insulin for California, has not started clinical trials ...

A University of Oklahoma professor and his team have discovered a new way to put atoms into drug molecules that could ...

How much money does the public sector invest in the development of medicines? The Austrian Institute for Health Technology Assessment (AIHTA) aims to shed light on this issue and uses antibiotics as ...

Benefiting from technological and conceptual groundwork and positive early data, gene therapies are advancing in the clinic ...